Your browser doesn't support javascript.
loading
In vitro cytocompatibility of triclosan coated Polyglactin910 sutures.
Ji, Hongrui; Zhang, Zhiruo; Wang, Chao; Li, Xuewen; Zhang, Guiling; Liu, Danqing.
Afiliação
  • Ji H; School of Materials Science and Chemical Engineering, Harbin University of Science and Technology, Harbin, 150040, Heilongjiang, China. jihongrui@hrbust.edu.cn.
  • Zhang Z; School of Materials Science and Chemical Engineering, Harbin University of Science and Technology, Harbin, 150040, Heilongjiang, China.
  • Wang C; School of Materials Science and Chemical Engineering, Harbin University of Science and Technology, Harbin, 150040, Heilongjiang, China.
  • Li X; School of Materials Science and Chemical Engineering, Harbin University of Science and Technology, Harbin, 150040, Heilongjiang, China.
  • Zhang G; School of Materials Science and Chemical Engineering, Harbin University of Science and Technology, Harbin, 150040, Heilongjiang, China. 2583678873@qq.com.
  • Liu D; School of Materials Science and Chemical Engineering, Harbin University of Science and Technology, Harbin, 150040, Heilongjiang, China. 450313845@qq.com.
J Mater Sci Mater Med ; 35(1): 35, 2024 Jun 20.
Article em En | MEDLINE | ID: mdl-38900360
ABSTRACT
Bioabsorbable sutures can improve the medical functions of existing non-absorbable sutures, and may produce new medical effects, and are expected to become a new generation of medical degradable materials. In this study, the cytocompatibility of triclosan coated polyglactin910 sutures (CTS-PLGA910) was analyzed and different concentrations of sutures were prepared. The effects of sutures on the cytotoxicity and cell proliferation of HUVEC were studied by CCK-8 assay. The hemolysis, total antioxidant capacity (T-AOC) activity and nitric oxide (NO) content were investigated to improve the blood compatibility of sutures. The results showed that the hemolysis rate of CTS-PLGA910 was less than 5%. After treatment on HUVEC cells for 48 and 72 h, there was no significant change in NO content in CTS-PLGA910 groups compared with the control group, while T-AOC activity and antioxidant capacity were significantly increased in medium and high dose groups. In summary, the blood compatibility and cell compatibility were significantly improved, which provided a basis for the clinical application of sutures in the future.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Poliglactina 910 / Suturas / Triclosan / Teste de Materiais / Materiais Revestidos Biocompatíveis / Proliferação de Células / Células Endoteliais da Veia Umbilical Humana Limite: Humans Idioma: En Revista: J Mater Sci Mater Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Poliglactina 910 / Suturas / Triclosan / Teste de Materiais / Materiais Revestidos Biocompatíveis / Proliferação de Células / Células Endoteliais da Veia Umbilical Humana Limite: Humans Idioma: En Revista: J Mater Sci Mater Med Ano de publicação: 2024 Tipo de documento: Article